General Information:
Id: | 113 (click here to show other Interactions for entry) |
Diseases: |
Alzheimer disease
- [OMIM]
|
Homo sapiens | |
BTO:0001760 myotubes (L6) | |
article | |
Reference: | Alessi DR et al.(1996) Mechanism of activation of protein kinase B by insulin and IGF-1 EMBO J. 15: 6541-6551 [PMID: 8978681] |
Interaction Information:
Comment | Insulin activated endogenous protein kinase Ba (also known as RAC/Akt kinase) activity 12-fold in L6 myotubes. |
Formal Description Interaction-ID: 385 |
|
Drugbank entries | Show/Hide entries for AKT1 |
Comment | Insulin activated endogenous protein kinase Ba (also known as RAC/Akt kinase) activity. The activation of AKT1 was accompanied by its phosphorylation at Thr3O8 and Ser473 and, like activation, phosphorylation of both of these residues was prevented by the phosphatidylinositol 3-kinase inhibitor wortmannin. |
Formal Description Interaction-ID: 395 |
|
Drugbank entries | Show/Hide entries for AKT1 |
Comment | Wortmannin is a phosphatidylinositol 3-kinase inhibitor. |
Formal Description Interaction-ID: 396 |
drug/chemical compound decreases_phosphorylation of gene/protein |
Drugbank entries | Show/Hide entries for AKT1 |